Syndexa Pharmaceuticals' Series B - III Round

Syndexa Pharmaceuticals raised a round of funding on January 05, 2012.

Syndexa Pharmaceuticals is dedicated to the discovery and development of drugs targeting biological mechanisms for the treatment and prevention of metabolic diseases including obesity, type 2 diabetes…

Articles about Syndexa Pharmaceuticals' Series B - III Round: